{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:52:09Z","timestamp":1792641129331,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.fertnstert.2021.07.1206","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:40:04Z","timestamp":1630532404000},"page":"936-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8947-6109","authenticated-orcid":false,"given":"Paul","family":"Pirtea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Desmedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T\u2019Sjoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.07.1206_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1176\/appi.ajp.2017.17060626","article-title":"Transgender research in the 21st century: a selective critical review from a neurocognitive perspective","volume":"174","author":"Mueller","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/818010","article-title":"The role of androgen hormones in early follicular development","volume":"2014","author":"Gerv\u00e1sio","year":"2014","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/jrf.0.1130027","article-title":"Effect of androgens on the development of mouse follicles growing in\u00a0vitro","volume":"113","author":"Murray","year":"1998","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib5","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib6","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations","volume":"83","author":"Weil","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(03)00735-0","article-title":"Androgen excess is the key element in polycystic ovary syndrome","volume":"80","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1210\/jcem-43-2-347","article-title":"The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome","volume":"43","author":"Judd","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-68-6-1111","article-title":"Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease","volume":"68","author":"de Ziegler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1991.tb00235.x","article-title":"Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?","volume":"19","author":"Pache","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib13","first-page":"15","article-title":"In\u00a0vitro production of androgens by a virilizing adrenal adenoma and associated polycystic ovaries","volume":"44","author":"Kase","year":"1963","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10815-019-01513-x","article-title":"Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy: a pilot study","volume":"36","author":"De Roo","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-69-1-151","article-title":"The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects","volume":"69","author":"Spinder","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals","volume":"62","author":"Futterweit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humrep\/des385","article-title":"Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology","volume":"28","author":"Ikeda","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humrep\/der406","article-title":"Reproductive wish in transsexual men","volume":"27","author":"Wierckx","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jsxm.2018.03.083","article-title":"Desire to have children among transgender people in Germany: a cross-sectional multi-center study","volume":"15","author":"Auer","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.fertnstert.2019.07.014","article-title":"Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine","volume":"112","author":"Leung","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/09540261.2015.1084275","article-title":"Fertility options in transgender people","volume":"28","author":"De Roo","year":"2016","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/jrf.0.0810433","article-title":"Morphometric studies of small follicles in ovaries of women at different ages","volume":"81","author":"Gougeon","year":"1987","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rbmo.2017.03.008","article-title":"Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment","volume":"34","author":"De Roo","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1711700107","article-title":"An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia","volume":"170","author":"Burgess","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1990.tb17801.x","article-title":"Effect of long-term administration of androgens on breast tissues of female-to-male transsexuals","volume":"586","author":"Sapino","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1373\/clinchem.2006.068932","article-title":"Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens","volume":"52","author":"Slagter","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib28","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jnci\/djh336","article-title":"Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women","volume":"96","author":"Missmer","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0277-5379(83)90389-9","article-title":"Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast","volume":"19","author":"Secreto","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib30","doi-asserted-by":"crossref","first-page":"l1652","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands","volume":"365","author":"de Blok","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MED.0000000000000064","article-title":"Management of female-to-male transgender persons: medical and surgical management, life expectancy","volume":"21","author":"Gooren","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.maturitas.2017.10.012","article-title":"Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: a cohort study","volume":"107","author":"Vita","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP15950.OR","article-title":"Metabolic effects of hormone therapy in transgender patients","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib34","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz247","article-title":"Muscle strength, size, and composition following 12 months of gender-affirming treatment in transgender individuals","volume":"105","author":"Wiik","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820985681","article-title":"Insulin resistance in transgender individuals correlates with android fat mass","volume":"12","author":"Bretherton","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib37","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1210\/jc.2012-1187","article-title":"Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy","volume":"97","author":"Van Caenegem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib38","doi-asserted-by":"crossref","first-page":"37005","DOI":"10.1038\/srep37005","article-title":"12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study","volume":"6","author":"Auer","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib39","article-title":"Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study","volume":"21","author":"Suppakitjanusant","year":"2020","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib41","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1210\/jc.2007-0746","article-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals","volume":"92","author":"Mueller","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib43","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/and.12660","article-title":"Cross-sex hormone therapy in transgender persons affects total body weight, body\u00a0fat and lean body mass: a meta-analysis","volume":"49","author":"Klaver","year":"2017","journal-title":"Andrologia"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jc.2017-01559","article-title":"Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines","volume":"103","author":"Auer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/dc19-1061","article-title":"Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people","volume":"43","author":"Shadid","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-20-0609","article-title":"Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care","volume":"183","author":"van Velzen","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib48","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2021.07.1206_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","article-title":"Gender differences in insulin resistance, body composition, and energy balance","volume":"6","author":"Geer","year":"2009","journal-title":"Gend Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib50","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0004563215587763","article-title":"A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria","volume":"53","author":"Seal","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2164\/jandrol.108.004952","article-title":"Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments","volume":"29","author":"Resmini","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4158\/EP-2017-0203","article-title":"Estrogen levels do not rise with testosterone treatment for transgender men","volume":"24","author":"Chan","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib56","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI84137","article-title":"Gonadal steroid-dependent effects on bone turnover and bone mineral density in men","volume":"126","author":"Finkelstein","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MED.0000000000000202","article-title":"Bone in trans persons","volume":"22","author":"Van Caenegem","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MED.0000000000000502","article-title":"Bone health in adult trans persons: an update of the literature","volume":"26","author":"Wiepjes","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib59","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.3102","article-title":"Bone mineral density increases in trans persons after 1 year of hormonal treatment: a multicenter prospective observational study","volume":"32","author":"Wiepjes","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.steroids.2014.05.004","article-title":"Outcomes of testosterone therapy in men with testosterone deficiency (TD): part II","volume":"88","author":"Traish","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib61","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","author":"Mueller","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jsxm.2021.01.185","article-title":"Does gender-affirming hormonal treatment affect 30-year cardiovascular risk in transgender persons? A two-year prospective European study (ENIGI)","volume":"18","author":"Cocchetti","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1196\/annals.1410.002","article-title":"Gender-specific regulation of the hypothalamo-pituitary-adrenal axis and the role of vasopressin\u00a0during the neonatal period","volume":"1148","author":"Makara","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib64","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib65","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen","volume":"104","author":"van Velzen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib66","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1447-0756.2008.00857.x","article-title":"Increased arterial stiffness in female-to-male transsexuals treated with androgen","volume":"34","author":"Emi","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib67","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/andr.12485","article-title":"Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence","volume":"6","author":"Defreyne","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2021.07.1206_bib69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221018100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221018100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:33:58Z","timestamp":1758011638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221018100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0015028221018100"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1206","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}